BioSpace News Archive

Relmada Therapeutics, Inc. today announced that Sergio Traversa , Chief Executive Officer, Maged Shenouda , Chief Financial Officer, and Cedric O’Gorman, Chief Medical Officer, will participate in the 2023 Jefferies Global Healthcare Conference in one-on-one investor meetings and a fireside chat on Thursday, June 8, 2023, at 3:00pm ET in New York, NY.

Illumina, Inc. today announced a series of governance changes consistent with the goal of enhancing long-term shareholder value.

Adaptive Biotechnologies Corporation will be included in several oral and poster presentations investigating the clinical significance of minimal residual disease (MRD) assessment at the American Society of Clinical Oncology (ASCO) Annual Meeting taking place June 2-6 in Chicago.

Freeline Therapeutics Holdings plc announced that its Chief Executive Officer Michael Parini will present at the 2023 Jefferies Healthcare Conference being held in New York on June 7-9, 2023.

Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, announced a presentation reporting durable continuous transfusion independence with imetelstat, the Company’s first-in-class telomerase inhibitor, in IMerge Phase 3 lower risk MDS patients.

BioNTech SE and OncoC4, Inc., announced positive preliminary data from the ongoing Phase 1/2 trial with the companies’ anti-CTLA-4 antibody candidate, BNT316/ONC-392, in a patient cohort with metastatic, PD-1-resistant non-small cell lung cancer.

Numinus Wellness Inc. today announced that Payton Nyquvest , Founder and CEO, will participate in a Water Tower Research Fireside Chat on Wednesday, June 7, 2023, at 1:00 p.m. ET / 10:00 a.m. PT.

Aldeyra Therapeutics to Participate in Fireside Chat at the Jefferies Global Healthcare Conference.